
Requiring institutions to inform participants who have completed therapy on SWOG-8892 (RT +/− cisplatin for nasopharyngeal cancer) about early study closure: Right idea, wrong patients
Robert J. Amdur, Elizabeth BankertVolume:
38
Année:
1997
Langue:
english
DOI:
10.1016/s0360-3016(97)89491-6
Fichier:
PDF, 186 KB
english, 1997